Related Experiment Video
Updated: May 30, 2026

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
Published on: May 2, 2013
Nonneoplastic mucocutaneous lesions in organ transplant recipients
Claudio Ponticelli1, Pier Luca Bencini
1Division of Nephrology, Istituto Scientifico Humanitas, Rozzano, Milan, Italy. claudio.ponticelli@fastwebnet.it
Abstract:
Nonneoplastic mucocutaneous lesions are frequent in organ transplant recipients. Many of them are caused by a direct toxicity of immunosuppressive drugs, in particular glucocorticoids and cyclosporine. The effects of these agents are dose- and time-dependent. Glucocorticoids can cause acne, Cushingoid appearance, irregular purpuric areas, friable skin, and wide and violaceous stripes. Cyclosporine can cause hypertrichosis, pilosebaceous lesions, and gum hypertrophy. Patients with esthetic changes may show poor adherence to treatment with these immunosuppressive agents that may lead to progressive graft dysfunction. Apart from this direct toxicity, vigorous immunosuppression may render the transplant recipients more susceptible to mucocutaneous infections. Fungal infection, viral warts, and bacterial folliculitis are the most frequent types of mucocutaneous infection. Some fungal infections, such as oral candidiasis and pityriasis versicolor, are relatively trivial, but other mycotic infections can cause severe or disfigurating lesions. Among viral infections, warts and condylomata caused by human papilloma virus are frequent and may favor the development of nonmelanoma skin cancer. Bacterial infections are usually trivial in the early period after transplantation, being represented almost exclusively by folliculitis. However, subcutaneous infections may cause a necrotizing fasciculitis which is a life-threatening disorder, usually sustained by polymicrobial pathogens.
Insights
Organ transplant recipients often develop mucocutaneous lesions due to immunosuppressive drugs like glucocorticoids and cyclosporine. These drug toxicities and increased infection susceptibility can impact treatment adherence and graft survival.
Area of Science:
- Dermatology
- Transplantation Medicine
Background:
- Nonneoplastic mucocutaneous lesions are common in organ transplant recipients.
- These lesions stem from direct immunosuppressive drug toxicity and heightened susceptibility to infections.
Purpose of the Study:
- To review the spectrum of nonneoplastic mucocutaneous lesions in organ transplant recipients.
- To discuss the etiological roles of immunosuppressive drugs and infections.
- To highlight the clinical implications for patient adherence and graft outcomes.
Main Methods:
- Literature review of nonneoplastic mucocutaneous lesions in organ transplant recipients.
- Analysis of drug-induced toxicities (glucocorticoids, cyclosporine).
- Categorization of infectious etiologies (fungal, viral, bacterial).
Main Results:
- Glucocorticoids cause acne, Cushingoid appearance, and skin changes; cyclosporine induces hypertrichosis and gum hypertrophy.
- Increased susceptibility to fungal, viral (human papilloma virus), and bacterial infections.
- Mucocutaneous changes can lead to poor treatment adherence and graft dysfunction.
Conclusions:
- Immunosuppressive drug toxicity and infections are significant causes of mucocutaneous lesions in transplant patients.
- Managing these lesions is crucial for improving patient adherence and long-term graft survival.
- Awareness of the diverse mucocutaneous manifestations is essential for transplant care teams.
Related Concept Videos
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Cell-mediated Immune Responses
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Kidney Transplant I: Introduction

